GB818336A - A new acid aminopolysaccharide and a process for the production thereof - Google Patents
A new acid aminopolysaccharide and a process for the production thereofInfo
- Publication number
- GB818336A GB818336A GB19656/57A GB1965657A GB818336A GB 818336 A GB818336 A GB 818336A GB 19656/57 A GB19656/57 A GB 19656/57A GB 1965657 A GB1965657 A GB 1965657A GB 818336 A GB818336 A GB 818336A
- Authority
- GB
- United Kingdom
- Prior art keywords
- per cent
- acid
- aminopolysaccharide
- per
- removal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
A new acid aminopolysaccharide is obtained from hog gastric mucosa by the following steps: (1) extraction of hog gastric mucosa with water; (2) treating the resulting extract with a protein precipitating agent which does not precipitate the acid aminopolysaccharide, preferably trichloracetic acid; (3) removal of the resulting precipitate e.g. by filtration; addition to the extract of a water-miscible organic solvent, for example about 1 1/2 volumes of acetone per volume of extract; (4) collection of the resulting solid; (5) suspension of the solid to about 5 per cent (w/v) in aqueous phenol of about 95 per cent concentration; (6) again collecting the solid material; (7) addition to the solid material of a buffer solution of pH between 4 and 5, e.g. 0.1M acetate buffer; (8) removal of insoluble matter; (9) one or more extraction with a water-immiscible organic polar solvent, conveniently a 1 : 1 mixture of chloroform and amyl alcohol; (10) removal of the solute from the aqueous phase, e.g. by freeze drying; (11) dissolution of the solute in an aqueous solution of a barium salt such as a 3 per cent solution of barium acetate; (12) removal of the resulting residue; (13) successive fractional additions of a water-soluble lower aliphatic alcohol such as ethanol, each addition being followed by removal of the resulting precipitate; (14) collection together of the fractions of the resulting precipitate of substantially pure acid aminopolysaccharide, preferably the fraction precipitated in the concentration range of 20-30 per cent; (15) dissolution of the collected fractions in water; (16) addition of a soluble sulphate, such as sodium sulphate; (17) removal of the resulting precipitate of barium sulphate; (18) dialysis of the remaining aqueous solution against distilled water until substantially no sulphate can be detected; (19) isolation of the acid aminopolysaccharide from solution, for example, by freeze-drying. The new acid aminopolysaccharide has the following characteristics-a relative viscosity of 1.87 in 0.5 per cent solution in 0.9 per cent sodium chloride at 37 DEG C., (a )D25 = 95 DEG \sB 1 DEG and electrophonetic mobility in phosphate buffer at pH 6.0 = -9.3 X 10-5 centimetres per second per volt in the ascending boundary and -8.9 X 10-5 centimetres per second per volt in the descending boundary, an analysis of 0.5 per cent sulphur, 34.8 per cent carbon, 5.6 per cent hydrogen, 3.2 per cent nitrogen and 55.9 per cent oxygen, 34.7 per cent hexuronic acid, 21.1 per cent hexosamine, 25.5 per cent reducing substances, 6.1 per cent acetyl groups and 1.6 per cent mineral substance. The acid aminopolysaccharide is soluble in water and gives a negative reaction to biuret, xanthoproteic, Millon, Hopkins-Cole, and Sakaguchi tests. It possesses in vitro and in vivo clearing action upon rabbit plasma, antilipemic and hypocholesterolemic action in rabbits and in man and protective action against dietary liver steatosis. A detailed example of the extraction of the acid aminopolysaccharide from hog gastric mucosa is given.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT818336X | 1956-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB818336A true GB818336A (en) | 1959-08-12 |
Family
ID=11317314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB19656/57A Expired GB818336A (en) | 1956-06-22 | 1957-06-21 | A new acid aminopolysaccharide and a process for the production thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB818336A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2579895A1 (en) * | 1985-04-05 | 1986-10-10 | Fidia Spa | |
US5631241A (en) * | 1983-10-10 | 1997-05-20 | Fidia S.P.A. | Pharmaceutical compositions containing hyaluronic acid fractions |
US5767106A (en) | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US5824658A (en) | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5910489A (en) | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5977088A (en) | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5990096A (en) | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6103704A (en) | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US6140312A (en) | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
CN109021127A (en) * | 2018-06-29 | 2018-12-18 | 北京工商大学 | A kind of extracting method of Polysaccharide from Portulaca oleracea |
-
1957
- 1957-06-21 GB GB19656/57A patent/GB818336A/en not_active Expired
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631241A (en) * | 1983-10-10 | 1997-05-20 | Fidia S.P.A. | Pharmaceutical compositions containing hyaluronic acid fractions |
FR2579895A1 (en) * | 1985-04-05 | 1986-10-10 | Fidia Spa | |
EP0197718A3 (en) * | 1985-04-05 | 1987-09-09 | Fidia Spa | New medicaments for topical use |
US4736024A (en) * | 1985-04-05 | 1988-04-05 | Fidia, S.P.A. | Process for preparing salt of hyaluronic acid with a pharmaceutically active substance |
US5824658A (en) | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5910489A (en) | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5962433A (en) | 1990-09-18 | 1999-10-05 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5990096A (en) | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US5977088A (en) | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6103704A (en) | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US6140312A (en) | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5767106A (en) | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
CN109021127A (en) * | 2018-06-29 | 2018-12-18 | 北京工商大学 | A kind of extracting method of Polysaccharide from Portulaca oleracea |
CN109021127B (en) * | 2018-06-29 | 2021-09-10 | 北京工商大学 | Extraction method of purslane polysaccharide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Highberger et al. | The interaction of mucoprotein with soluble collagen; an electron microscope study | |
GB818336A (en) | A new acid aminopolysaccharide and a process for the production thereof | |
Berenson | A study of acid mucopolysaccharides of bovine aorta with the aid of a chromatographic procedure for separating sulfated mucopolysaccharides | |
Partridge et al. | The chemistry of connective tissues. 4. The presence of a non-collagenous protein in cartilage | |
Stevely et al. | Phosphorylation of rat-thymus histone | |
Harington et al. | The detection of hyaluronic acid in pleural fluids of cases with diffuse pleural mesotheliomas | |
US4544552A (en) | Process for the preparation of cell and tissue regenerating substances | |
Pras et al. | The significance of mucopolysaccharides in amyloid | |
Jorpes | On the chemistry of heparin | |
US3454560A (en) | Process for the production of chondroitin polysulfate | |
Ukai et al. | Polysaccharides in Fungi. I. Purification and characterization of acidic heteroglycans from aqueous extract of Tremella Fuciformis Berk | |
Irving Jr et al. | Purification of the pressor principle of the posterior lobe of the pituitary gland by electrophoresis | |
US2638469A (en) | Process for alginic acid sulfate production | |
US3607650A (en) | Process for the enzymatic extraction and purification of a glycopeptide obtained from animal organs,useful as a drug | |
US3066135A (en) | Process for the preparation of hexose alkali metal salts of hexose diphosphate from insoluble salts thereof | |
NL183218C (en) | METHOD FOR SEPARATING IRON COMPOUNDS FROM THE PROTEIN IN A HEMOGLOBINE SOLUTION. | |
GB1486290A (en) | Polypeptide with serum calcium lowering properties | |
Satoh | Biochemical Studies on Carbohydrates CXVI. Group-specific Substances in Gastric Mucosa. Third Communication: Group-specific Carbohydrates from Human Gastric Mucosa | |
US3211616A (en) | N, o-sulfated neutral-mucopolysaccharide | |
Virupaksha et al. | The reaction of insulin with N-acetyl-Dl-homocysteine thiolactone: some chemical and biological properties of the products | |
GB1344727A (en) | Pharmaceutical preparations comprising chondroitin sulphates a and c | |
US3872075A (en) | Salts of amino-acids with polysulfuric esters of natural gly-copeptides and process for preparing same | |
Jorpes et al. | Studies on the A-Antigenic Polysaccharide from the Abomasus of Cattle | |
US3267090A (en) | Viscumic acid and salts thereof | |
US3803119A (en) | Pantetheine-s-sulfonic acid derivatives and salts thereof |